insights_auto
Why is BBOT down 2.78%?
Dive Deeperchevron_right
BBOT:NASDAQ
BridgeBio Oncology Therapeutics Inc
$3.50
arrow_downward
-2.78%(-0.100) 1D
$3.50
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBOT...
Open
$3.60
High
$3.72
Low
$3.48
Mkt. cap
303.21M
Avg. vol.
647.50K
Volume
20.00
52-wk high
$14.87
52-wk low
$3.48
EPS
-$3.04
Shares outstanding
80.17M
No. of employees
88
Open
$3.60
High
$3.72
Low
$3.48
Mkt. cap
303.21M
Avg. vol.
647.50K
Volume
20.00
52-wk high
$14.87
52-wk low
$3.48
EPS
-$3.04
Shares outstanding
80.17M
No. of employees
88
News stories
From web sources and news partners
Stock Titan
·
6 minutes ago
A Korean company completed quantum projects in materials and rail scheduling. A deal is expected to take it to Nasdaq.
PR Newswire
·
36 minutes ago
Fluence Energy (NASDAQ: FLNC) Faces Securities Class Action Amid Inability to Ramp Houston Facility - HBSS
Yahoo Finance
·
1 hour ago
AST SpaceMobile (ASTS) Completed Its First Direct Satellite To Smartphone Test In Canada
CNBC
·
51 minutes ago
AI trade driving stocks, but questions remain over rest of market
About BridgeBio Oncology Therapeutics Inc
CEO-
Employees88
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitebbotx.com